ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Identification of Fangjihuangqi Decoction as a late-stage autophagy inhibitor with an adjuvant anti-tumor effect against non-small cell lung cancer

Chen, Qiugu; Liao, Yuan; Liu, Yujiao; Song, Yue; Jiang, Junbo; Zhang, Zhen; Li, Anqi; Zheng, Mengyi; Chen, Xiaoyi; Zhao, Tingxiu; Gu, Jiangyong; Tan, Yuhui; Liu, Xiaoyi; Jiang, Yanjun; Wang, Kun; Yi, Hua*; Xiao, Jianyong*; Hu, Shan*广州中医药大学
Chinese Medicine2023-6-7DOI: 10.1186/s13020-023-00770-4
9阅读
引用收藏
分享

摘要

BackgroundClinically, although chemotherapy is one of the most commonly used methods of treating tumors, chemotherapeutic drugs can induce autophagic flux and increase tumor cell resistance, leading to drug tolerance. Therefore, theoretically, inhibiting autophagy may improve the efficacy of chemotherapy. The discovery of autophagy regulators and their potential application as adjuvant anti-cancer drugs is of substantial importance. In this study, we clarified that Fangjihuangqi Decoction (FJHQ, traditional Chinese medicine) is an autophagy inhibitor, which can synergistically enhance the effect of cisplatin and paclitaxel on non-small cell lung cancer (NSCLC) cells.MethodsWe observed the changes of autophagy level in NSCLC cells under the effect of FJHQ, and verified the level of the autophagy marker protein and cathepsin. Apoptosis was detected after the combination of FJHQ with cisplatin or paclitaxel, and NAC (ROS scavenger) was further used to verify the activation of ROS-MAPK pathway by FJHQ.ResultsWe observed that FJHQ induced autophagosomes in NSCLC cells and increased the levels of P62 and LC3-II protein expression in a concentration- and time-gradient-dependent manner, indicating that autophagic flux was inhibited. Co-localization experiments further showed that while FJHQ did not inhibit autophagosome and lysosome fusion, it affected the maturation of cathepsin and thus inhibited the autophagic pathway. Finally, we found that the combination of FJHQ with cisplatin or paclitaxel increased the apoptosis rate of NSCLC cells, due to increased ROS accumulation and further activation of the ROS-MAPK pathway. This synergistic effect could be reversed by NAC.ConclusionCollectively, these results demonstrate that FJHQ is a novel late-stage autophagy inhibitor that can amplify the anti-tumor effect of cisplatin and paclitaxel against NSCLC cells.

学科与关键词

关键词
Fangjihuangqi decoctionAutophagy inhibitionSensitizationCisplatinPaclitaxel
相关
加载中…
  • Deciphering the Effects and Mechanisms of Yi-Fei-San-Jie-pill on Non-Small Cell Lung Cancer With Integrating Network Target Analysis and Experimental Validation
    Yang, Hongxing; Guo, Qiuyan; Wu, Jianbin; Zhong, Lixia; Sun, Lingling; Liu, Wei; Wang, Jigang*; Lin, Lizhu*Frontiers in Pharmacology, 2022, 13: 851554.被引 2
  • Xie-Bai-San increases NSCLC cells sensitivity to gefitinib by inhibiting Beclin-1 mediated autophagosome formation
    Ma, Changju; Zhang, Xin; Mo, Xiaomin; Yu, Yaya; Xiao, Zhenzhen; Wu, Jingjing; Ding, Lina; Lei, Chenjing; Zhu, Yanjuan*; Zhang, Haibo*PHYTOMEDICINE, 2024, 125: 155351.
  • Investigating the efficacy and mechanisms of Jinfu'an decoction in treating non-small cell lung cancer using network pharmacology and in vitro and in vivo experiments
    Peng, Huiting; Huang, Zhongming; Li, Peiqin; Sun, Zhe; Hou, Xuenan; Li, Zeyun; Sang, Ran; Guo, Zehuai; Wu, Siqi; Cao, Yang*Journal of Ethnopharmacology, 2024, 321: 117518.
查看全部 →

发表信息

论文状态
公开发表
期刊
Chinese Medicine
发表日期
2023-06-07
卷期
第 18 卷, 第 1 期
页码
68
DOI
10.1186/s13020-023-00770-4
语言
ENGLISH
成果收录
SCIE

作者

  • C

    Chen, Qiugu (第一作者)

    guangzhou univ chinese med

  • L

    Liao, Yuan

    guangzhou univ chinese med

查看全部 18 位作者收起作者
  • L

    Liu, Yujiao

    guangzhou univ chinese med

  • S

    Song, Yue

    guangzhou univ chinese med

  • J

    Jiang, Junbo

    guangzhou univ chinese med

  • Z

    Zhang, Zhen

    guangzhou univ chinese med

  • L

    Li, Anqi

    guangzhou univ chinese med

  • Z

    Zheng, Mengyi

    guangzhou univ chinese med

  • C

    Chen, Xiaoyi

    2 · guangzhou univ chinese med

  • Z

    Zhao, Tingxiu

    guangzhou univ chinese med

  • G

    Gu, Jiangyong

    guangzhou univ chinese med

  • T

    Tan, Yuhui

    guangzhou univ chinese med

  • L

    Liu, Xiaoyi

    guangzhou univ chinese med

  • J

    Jiang, Yanjun

    chinese univ hong kong

  • W

    Wang, Kun

    guangzhou univ chinese med

  • Y

    Yi, Hua (通讯)

    guangzhou univ chinese med

  • X

    Xiao, Jianyong (通讯)

    guangzhou univ chinese med

  • H

    Hu, Shan (通讯)

    guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417